Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB. (Q42971407)
Jump to navigation
Jump to search
scientific article published on July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB. |
scientific article published on July 2010 |
Statements
1 reference
Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB. (English)
1 reference
Kamran Khan
1 reference
Dick Menzies
1 reference
Anne Aspler
1 reference
Richard Long
1 reference
Anete Trajman
1 reference
Marie-Josée Dion
1 reference
Kevin Schwartzman
1 reference
1 July 2010
1 reference
1 reference
65
1 reference
7
1 reference
582-587
1 reference
Identifiers
1 reference
1 reference